Antibody (1)
Launched (1)
Rabbit (1)
- (1)
Unconjugated (1)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature | Order Now |
|---|---|---|---|---|---|---|---|
NG4-S455 | - | Polyclonal NG2/Cspg4 Antibody, Rabbit IgG |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Carotuximab | DE-122; TRC-105; Chimeric Antibody TRC-105; NSC#754227 | Phase 2 Clinical | Roswell Park Cancer Institute | Prostatic Neoplasms; Carcinoma, Non-Small-Cell Lung; Macular Degeneration; Carcinoma, Hepatocellular; Neoplasm Metastasis; Metastatic breast cancer; Adenoma, Liver Cell; Lung Neoplasms; Fallopian Tube Neoplasms; Glioma; Trophoblastic Tumor, Placental Site; Choriocarcinoma; Ureteral Neoplasms; Astrocytoma; Gliosarcoma; Peritoneal Neoplasms; Ovarian Neoplasms; Brain Neoplasms; Breast Neoplasms; Sarcoma; Oligodendroglioma; Prostatic Neoplasms, Castration-Resistant; Gestational Trophoblastic Disease; Liver Neoplasms, Experimental; Carcinoma, Transitional Cell; Neoplasms; Glioblastoma; Hemangiosarcoma; Trophoblastic Neoplasms; Carcinoma, Renal Cell; Liver Neoplasms; Solid tumours | Details |
| STEMVAC | EP-101 | Phase 2 Clinical | Epithany | Triple Negative Breast Neoplasms; Breast Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| ENV-105 | ENV-105 | Phase 2 Clinical | Kairos Pharma Ltd | Prostatic Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland



